Neuropilin 1 anticorps (Alexa Fluor 647)

N° du produit ABIN2657169

Détail du produit anti-Neuropilin 1 anticorps (Alexa Fluor 647)

Antigène: Neuropilin 1 (NRP1)

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Neuropilin 1 est conjugé à/à la Alexa Fluor 647

Application: Flow Cytometry (FACS), Immunoprecipitation (IP)

Purification: The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 647 under optimal conditions.

Clone: 12C2

Isotype: IgG2a kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Protect from prolonged exposure to light. Do not freeze.

Stock: 4 °C

Stockage commentaire: The antibody solution should be stored undiluted between 2°C and 8°C

Détails sur Neuropilin 1

Antigène: Neuropilin 1 (NRP1)

Autre désignation: CD304 (NRP1 Produits)

Synonymes: anticorps NRP1, anticorps cd304, anticorps neuropilin, anticorps np-1, anticorps npn-1, anticorps nrp, anticorps nrp-1, anticorps vegf165r, anticorps BDCA4, anticorps CD304, anticorps NP1, anticorps NRP, anticorps VEGF165R, anticorps C530029I03, anticorps NP-1, anticorps NPN-1, anticorps Npn1, anticorps Nrp, anticorps neuropilin 1, anticorps neuropilin 1 L homeolog, anticorps NRP1, anticorps nrp1, anticorps Nrp1, anticorps nrp1.L

Sujet: CD304, also known as neuropilin-1, BDCA-4 and VEGF165R, is a 140 kD type I transmembrane protein. Its extracellular region contains 2 CUB, 2 FV/FVIII, and one MAM domain, a soluble isoform is produced by alternative mRNA splicing. CD304 is involved in angiogenesis, neural development, and tumor metastasis. It's expressed by plasmacytoid dendritic cells, thymocytes, neurons, endothelium, and a subset of TFH cells. CD304 is also expressed in several carcinomas, and a high expression of this molecule in prostate cancer correlates with a poor prognosis.

Pathways: Regulation of Cell Size, Signaling Events mediated by VEGFR1 and VEGFR2, Smooth Muscle Cell Migration, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals